Tech Company Financing Transactions
PharmEnable Funding Round
MP Healthcare Venture Management, Arrowfield Capital and Cambridge Enterprise invested in a $7.5 million funding round for PharmEnable. The round was announced on 5/22/2023.
Transaction Overview
Company Name
Announced On
5/22/2023
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to advance and expand its portfolio of wholly owned and co-discovery projects across oncology and neurology targets, as well as supporting further platform R&D.
Company Information
Company Status
Private & Independent
Industry
AdTech
Mailing Address
Compass House, Vision Park Histon
Cambridge, England, CB24 9AD
UK
Cambridge, England, CB24 9AD
UK
Phone
Undisclosed
Website
Email Address
Overview
PharmEnable is a Cambridge (UK) based drug discovery company, using a combination of medicinal chemistry and AI computational approaches to design the next generation of specific and cost-efficient small molecule drugs. Our mission is to discover new treatments for otherwise undruggable conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hannah Sore
Chief Scientific Officer
Natalia Mateu
Co-Founder
Jelena Aleksic
Co-Founder
David Spring
Browse more venture capital transactions:
Prev: 5/22/2023: Accelergen Energy venture capital transaction
Next: 5/22/2023: Leadoptik venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to document every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs